A citation-based method for searching scientific literature

Ingo Vernaleken, Hans-Georg Buchholz, Yoshitaka Kumakura, Thomas Siessmeier, Peter Stoeter, Peter Bartenstein, Paul Cumming, Gerhard Gründer. Hum Brain Mapp 2007
Times Cited: 51



Stephen McGowan, Andrew D Lawrence, Tim Sales, Digby Quested, Paul Grasby. Arch Gen Psychiatry 2004
Times Cited: 149




List of shared articles



Times cited


The downside of downregulation.
Gerhard Gründer, Paul Cumming. Brain 2019
2

Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects.
Ingo Vernaleken, Yoshitaka Kumakura, Hans-Georg Buchholz, Thomas Siessmeier, Ralf-Dieter Hilgers, Peter Bartenstein, Paul Cumming, Gerhard Gründer. Neuroimage 2008
24

Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
Mihai Avram, Felix Brandl, Jorge Cabello, Claudia Leucht, Martin Scherr, Mona Mustafa, Stefan Leucht, Sibylle Ziegler, Christian Sorg. Brain 2019
18



Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?
Nora S Vyas, Neva H Patel, Kuldip S Nijran, Adil Al-Nahhas, Basant K Puri. Nucl Med Commun 2010
6

The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.
Alice Egerton, Arsime Demjaha, Philip McGuire, Mitul A Mehta, Oliver D Howes. Neuroimage 2010
71

Pathway-Specific Dopamine Abnormalities in Schizophrenia.
Jodi J Weinstein, Muhammad O Chohan, Mark Slifstein, Lawrence S Kegeles, Holly Moore, Anissa Abi-Dargham. Biol Psychiatry 2017
133

Executive function, neural circuitry, and genetic mechanisms in schizophrenia.
Daniel Paul Eisenberg, Karen Faith Berman. Neuropsychopharmacology 2010
149